Recombinant UPF0336 protein MAP_3996c (MAP_3996c)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during ordering. We will accommodate your request whenever possible.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a guideline for your reference.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is crucial for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
MAP_3996c; UPF0336 protein MAP_3996c
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-174
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Mycobacterium paratuberculosis (strain ATCC BAA-968 / K-10)
Target Names
MAP_3996c
Target Protein Sequence
MTVPKEAEGL IGSHYRAPDY FEVGREKIRE FALAVKDDHP AHFDESESAA AGYPDMVAPL TFLAIAGRRV QLEIFTKFSI PINIARVIHR DQKFKFHRPI LAHDRLYFDT YLDSVIESHG TVLAEIRSEV TDADGKPIVT SVVTMLGEAA HQEADAAATA AAVASISAGK LGAI
Uniprot No.

Q&A

What is UPF0336 protein MAP_3996c and what is its function?

UPF0336 protein MAP_3996c is a hypothetical protein from Mycobacterium avium subspecies paratuberculosis. As a member of the UPF (Uncharacterized Protein Family) 0336, its precise function remains under investigation. Current research suggests it may be involved in cellular processes typical of mycobacterial species, potentially participating in cell wall maintenance or stress responses. The protein is classified as "hypothetical" because its function has been predicted through computational analysis rather than experimental validation .

Research approaches to determine its function typically include:

  • Sequence homology analysis with proteins of known function

  • Structural prediction to identify functional domains

  • Gene knockout studies to assess phenotypic changes

  • Protein-protein interaction studies to identify binding partners

  • Transcriptomic analysis to determine expression patterns under various conditions

What expression systems are available for producing recombinant UPF0336 protein MAP_3996c?

Recombinant UPF0336 protein MAP_3996c can be produced using multiple expression systems, each with distinct advantages depending on your research requirements. Available expression systems include:

  • Baculovirus expression system: Suitable for producing proteins that require eukaryotic post-translational modifications

  • E. coli expression system: Typically provides high yields and is cost-effective for basic structural studies

  • Mammalian cell expression systems: Optimal for proteins requiring complex mammalian-specific modifications

  • Yeast expression systems: Balances higher eukaryotic processing capabilities with relatively high yields

The choice of expression system should be determined by your specific experimental requirements, including the need for post-translational modifications, protein folding considerations, and downstream applications.

How can researchers optimize purification of recombinant UPF0336 protein MAP_3996c?

Optimizing purification of recombinant UPF0336 protein MAP_3996c requires a systematic approach based on the protein's properties and the expression system used. The protein can be produced with various tags, including His-Tag, according to specific research needs .

A general purification workflow includes:

  • Cell lysis optimization: Buffer composition (pH, salt concentration, detergents) should be adjusted based on the protein's predicted characteristics

  • Initial capture: For His-tagged versions, immobilized metal affinity chromatography (IMAC) using Ni-NTA or Co-NTA resins

  • Intermediate purification: Ion exchange chromatography based on the protein's theoretical isoelectric point

  • Polishing: Size exclusion chromatography to achieve high purity

  • Quality control: SDS-PAGE, Western blot, and mass spectrometry to confirm identity and purity

For challenging purifications, consider:

  • Using mild detergents if aggregation occurs

  • Adding reducing agents if the protein contains cysteines

  • Optimizing temperature during purification steps

  • Including protease inhibitors to prevent degradation

What are the optimal conditions for maintaining structural integrity of UPF0336 protein during experimental procedures?

Maintaining the structural integrity of UPF0336 protein MAP_3996c requires careful consideration of buffer conditions and storage parameters. While specific stability data for this protein is limited, general principles for recombinant protein handling apply:

Buffer optimization should include:

  • pH stability testing across physiologically relevant ranges (pH 6.0-8.0)

  • Salt concentration optimization (typically 50-300 mM NaCl)

  • Addition of stabilizing agents such as glycerol (10-20%)

  • Evaluation of reducing agents (DTT, β-mercaptoethanol) if cysteine residues are present

Storage recommendations:

  • Short-term (1-2 weeks): 4°C with appropriate preservatives

  • Medium-term: -20°C in single-use aliquots with cryoprotectants

  • Long-term: -80°C with stabilizing additives

Thermal stability assessments using differential scanning fluorimetry can help identify optimal buffer conditions that maximize protein stability for specific experimental applications.

How can researchers validate the functional activity of recombinant UPF0336 protein MAP_3996c?

Validating the functional activity of UPF0336 protein MAP_3996c presents unique challenges due to its hypothetical nature. A comprehensive validation strategy might include:

  • Structural integrity assessment:

    • Circular dichroism to confirm secondary structure elements

    • Size exclusion chromatography to verify monodispersity

    • Dynamic light scattering to assess aggregation state

  • Binding studies:

    • Pull-down assays with potential interaction partners

    • Surface plasmon resonance to quantify binding kinetics

    • Isothermal titration calorimetry for thermodynamic parameters

  • Functional assays:

    • Based on bioinformatic predictions of potential enzymatic activity

    • Complementation studies in knockout models

    • Cellular localization studies using fluorescently tagged constructs

  • Comparative analysis:

    • Activity comparison between different expression systems

    • Assessment of the impact of tags on protein function

    • Evaluation of post-translational modifications on activity

What are the considerations for designing experiments to study protein-protein interactions involving UPF0336 protein?

Designing robust experiments to investigate protein-protein interactions involving UPF0336 protein MAP_3996c requires careful experimental planning:

  • Bait protein preparation:

    • Recombinant UPF0336 protein can be expressed with various tags appropriate for interaction studies

    • Consider N-terminal versus C-terminal tags based on structural predictions

    • Validate that tags don't interfere with potential interaction domains

  • In vitro interaction methods:

    • Co-immunoprecipitation with antibodies against the tag or protein

    • GST pull-down assays if using GST-tagged constructs

    • Crosslinking mass spectrometry to capture transient interactions

    • Proximity labeling approaches (BioID, APEX) for weak or transient interactions

  • Cell-based approaches:

    • Yeast two-hybrid screening to identify novel binding partners

    • Mammalian two-hybrid for validation in more relevant cellular contexts

    • Fluorescence resonance energy transfer (FRET) for real-time interaction monitoring

    • Bimolecular fluorescence complementation to visualize interactions in situ

  • Data analysis considerations:

    • Implementation of appropriate controls to distinguish specific from non-specific interactions

    • Quantitative analysis of binding affinities

    • Correlation of interaction data with functional outcomes

How do different expression systems affect the properties of recombinant UPF0336 protein?

The choice of expression system significantly impacts the properties of recombinant UPF0336 protein MAP_3996c, potentially affecting experimental outcomes:

Expression SystemAdvantagesLimitationsBest For
BaculovirusEukaryotic PTMs, proper folding, high yieldsTime-consuming, technically demandingStructural studies requiring PTMs
E. coliHigh yield, cost-effective, rapid productionLimited PTMs, inclusion body formation possibleBasic biochemical studies, crystallography
Mammalian CellNative-like PTMs, proper foldingLower yields, expensive, time-consumingFunctional studies requiring authentic structure
YeastModerate PTMs, relatively high yieldsSpecies-specific glycosylation patternsBalance between yield and processing needs

When selecting an expression system, consider:

  • The native cellular environment of the protein (prokaryotic vs. eukaryotic)

  • Required post-translational modifications for function

  • Downstream application requirements

  • Resource and time constraints

Some researchers opt for parallel expression in multiple systems to compare protein properties and identify the optimal approach for their specific research questions .

What quality control methods are essential when working with recombinant UPF0336 protein?

Implementing rigorous quality control procedures is crucial when working with recombinant UPF0336 protein MAP_3996c to ensure experimental reliability and reproducibility:

  • Purity assessment:

    • SDS-PAGE with Coomassie or silver staining (target >95% purity)

    • Densitometry analysis to quantify contaminants

    • Western blotting using tag-specific or protein-specific antibodies

  • Identity confirmation:

    • Mass spectrometry (MALDI-TOF or LC-MS/MS)

    • N-terminal sequencing for absolute identity confirmation

    • Peptide mapping against theoretical digestion patterns

  • Structural integrity:

    • Circular dichroism spectroscopy to verify secondary structure

    • Fluorescence spectroscopy to assess tertiary structure

    • Dynamic light scattering to evaluate size distribution and aggregation state

  • Functional verification:

    • Activity assays based on predicted function

    • Binding studies with known or predicted partners

    • Stability testing under experimental conditions

  • Contaminant testing:

    • Endotoxin testing for proteins expressed in bacterial systems

    • Host cell protein ELISA to quantify process-related impurities

    • Nucleic acid contamination assessment via absorbance ratios

Batch-to-batch consistency is emphasized in recombinant protein production to ensure experimental reproducibility .

How can researchers troubleshoot expression and purification challenges with UPF0336 protein?

When encountering difficulties with expression and purification of UPF0336 protein MAP_3996c, a systematic troubleshooting approach is recommended:

Expression Challenges:

  • Low expression levels:

    • Optimize codon usage for the expression host

    • Test different promoters and induction conditions

    • Consider fusion tags that enhance solubility (SUMO, MBP, Thioredoxin)

    • Evaluate co-expression with chaperones for improved folding

  • Inclusion body formation (E. coli):

    • Lower induction temperature (16-25°C)

    • Reduce inducer concentration

    • Use specialized E. coli strains (e.g., Origami for disulfide bond formation)

    • Consider refolding protocols if inclusion bodies persist

Purification Challenges:

  • Poor binding to affinity resins:

    • Verify tag accessibility (N vs. C-terminal positioning)

    • Optimize binding conditions (pH, salt, imidazole concentration)

    • Test alternative affinity tags

    • Consider native purification strategies

  • Protein degradation:

    • Include protease inhibitors throughout purification

    • Reduce purification time and temperature

    • Identify and eliminate specific proteolytic cleavage sites

    • Consider site-directed mutagenesis of protease-sensitive regions

  • Aggregation issues:

    • Screen buffers with varying pH, salt, and additives

    • Add stabilizing agents (glycerol, arginine, trehalose)

    • Remove tags that might contribute to aggregation

    • Consider detergents for hydrophobic proteins

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.